Table 1.
Demographic and clinical characteristics of VM and HC groups
| Items | VM group (n = 55) |
HC group (n = 57) |
P |
|---|---|---|---|
| Age (years) | 45.89 ± 12.29 | 45.86 ± 12.37 | 0.848a |
| Sex (male/female) | 8/47 | 9/48 | 0.854b |
| Education level (years) | 10.47 ± 4.79 | 11.89 ± 4.77 | 0.171a |
| Migraine disease duration (years) | 11.79 ± 11.21 | - | - |
| Vertigo disease duration (years) | 6.95 ± 8.61 | - | - |
| Headache frequency/month | 2.32 ± 2.44 | - | - |
| VAS | 6.33 ± 2.03 | - | - |
| DHI | 52.25 ± 17.04 | - | - |
| MIDAS | 11.26 ± 11.77 | - | - |
| HIT-6 | 55.15 ± 12.73 | - | - |
| PHQ-9 | 6.36 ± 5.61 | - | - |
| GAD-7 | 5.04 ± 4.43 | - | - |
Data were presented as mean ± standard deviation unless otherwise indicated
VM = vestibular migraine; HC = healthy control; VAS = Visual Analog Scale; DHI = Dizziness Handicap Inventory; MIDAS = Migraine Disability Assessment Scale; HIT-6 = Headache Impact Test-6; PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalized Anxiety Disorder-7; n = number of subjects
a P value with Mann–Whitney U test
b P value with Chi-square test